Lebanon VA Medical Center Surgical Clinic 1700 S Lincoln Ave, Lebanon, PA 17042 7172726621 (phone), 7172286118 (fax)
Education:
Medical School Sun Yat Sen Univ of Med Sci, Guangzhou, China (242 21 Pr 1/71) Graduated: 1982
Procedures:
Bone Marrow Biopsy Chemotherapy
Conditions:
Anemia Iron Deficiency Anemia Non-Hodgkin's Lymphoma Breast Neoplasm, Malignant Hemolytic Anemia
Languages:
English
Description:
Dr. Liu graduated from the Sun Yat Sen Univ of Med Sci, Guangzhou, China (242 21 Pr 1/71) in 1982. He works in Lebanon, PA and specializes in Hematology/Oncology and Internal Medicine. Dr. Liu is affiliated with Lebanon VA Medical Center.
Garfield Health Center 210 N Garfield Ave STE 203, Monterey Park, CA 91754 6263077397 (phone), 6263071807 (fax)
Education:
Medical School Hunan Med Univ, Changsha City, Hunan, China Graduated: 1985
Languages:
Chinese English Spanish Vietnamese
Description:
Dr. Liu graduated from the Hunan Med Univ, Changsha City, Hunan, China in 1985. She works in Monterey Park, CA and specializes in Internal Medicine. Dr. Liu is affiliated with Garfield Medical Center and Pacific Alliance Medical Center.
JOHN M. HARLAN - SEATTLE WA, US ROBERT K. WINN - BAINBRIDGE ISLAND WA, US LI LIU - REDMOND WA, US
Assignee:
UNIVERSITY OF WASHINGTON
International Classification:
A61K009/00
US Classification:
424/400000
Abstract:
The present invention provides an aerosol formulation of a 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase inhibitor. The HMG-CoA reductase inhibitor can be, for example, a statin such as lovastatin, pravastatin, simvastatin, cerivastatin, fluvastatin, atorvastatin or mevastatin. The invention also provides a method of treating a pulmonary disease with an aerosol formulation of a HMG-CoA reductase inhibitor.
Methods And Compositions For Prevention Or Treatment Of Inflammatory-Related Diseases And Disorders
John M. Harlan - Seattle WA, US Lynn M. Schnapp - Seattle WA, US Barbara R. Schwartz - Seattle WA, US Li Liu - Sammamish WA, US Elaine White Raines - Seattle WA, US Yoshiaki Tsubota - Seattle WA, US
Methods and compositions are provided for treating inflammatory-related diseases and related disorders in a mammalian subject. The method provides administering to the mammalian subject one or more modulators of cyclin dependent kinase 4 (Cdk4) activity in an amount effective to reduce or eliminate the inflammatory-related disease or disorder or prevent its occurrence or recurrence. Methods are also provided for reducing or eliminating ligand-induced adhesion in a mammalian subject. The method provides administering to the subject one or more modulators of cyclin dependent kinase 4 (Cdk4) activity in an amount effective to reduce or eliminate ligand-induced adhesion.
Isbn (Books And Publications)
The Chinese Neolithic: Trajectories To Early States